V
VISTAGEN THERAPEUTICS INC
NASDAQ: VTGN (VistaGen Therapeutics, Inc.)
Last update: 29 minutes ago0.244
0.00 (-0.08%)
| Previous Close | 0.244 |
| Open | 0.239 |
| Volume | 476,815 |
| Avg. Volume (3M) | 4,108,935 |
| Market Cap | 10,819,091 |
| Price / Sales | 3.89 |
| Price / Book | 0.430 |
| 52 Weeks Range | |
| Earnings Date | 12 Nov 2026 |
| Operating Margin (TTM) | 96,633.34% |
| Diluted EPS (TTM) | -1.67 |
| Quarterly Revenue Growth (YOY) | -43.10% |
| Total Debt/Equity (MRQ) | 2.14% |
| Current Ratio (MRQ) | 6.51 |
| Operating Cash Flow (TTM) | -42.10 M |
| Levered Free Cash Flow (TTM) | -23.27 M |
| Return on Assets (TTM) | -33.64% |
| Return on Equity (TTM) | -55.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | VistaGen Therapeutics, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.5
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.50 |
|
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 0.35% |
| % Held by Institutions | 52.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Commodore Capital Lp | 30 Jun 2026 | 2,788,620 |
| Stempoint Capital Lp | 30 Jun 2026 | 616,749 |
| Advisorshares Investments Llc | 30 Jun 2026 | 438,643 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |